TORRENT PHARMACEUTICALS
Back to Balance Sheet
|
TORRENT PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹2,088 Cr | ₹2,224 Cr | ₹2,823 Cr | ₹2,238 Cr | ₹2,924 Cr |
What is the latest Total Non-Current Liabilities ratio of TORRENT PHARMACEUTICALS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹2,088 Cr |
| Mar2024 | ₹2,224 Cr |
| Mar2023 | ₹2,823 Cr |
| Mar2022 | ₹2,238 Cr |
| Mar2021 | ₹2,924 Cr |
How is Total Non-Current Liabilities of TORRENT PHARMACEUTICALS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,088 Cr | -6.13 | |
| Mar2024 | ₹2,224 Cr | -21.21 | |
| Mar2023 | ₹2,823 Cr | 26.12 | |
| Mar2022 | ₹2,238 Cr | -23.46 | |
| Mar2021 | ₹2,924 Cr | - | |
Compare Total Non-Current Liabilities of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹139,892.9 Cr | -0.5% | -4% | 29.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹399,549.0 Cr | -1.9% | -7.3% | -2.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,862.0 Cr | 1.8% | 3.3% | 9.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,891.0 Cr | 0.2% | -4.9% | 6.6% | Stock Analytics | |
| CIPLA | ₹99,591.5 Cr | 0.5% | -3.8% | -17% | Stock Analytics | |
| MANKIND PHARMA | ₹90,642.6 Cr | 3.4% | 6.2% | -11.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | -0.5% |
-4% |
29.9% |
| SENSEX | 3.2% |
5% |
5.5% |
You may also like the below Video Courses